Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroblastoma × Restraint, Physical × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 7 Uterine Cervical Neoplasms 5 Neoplasms 5 Head and Neck Neoplasms 5 Prostatic Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Melanoma 3 Hematologic Neoplasms 3 Uterine Cervical Dysplasia 2 Sarcoma 2 Pancreatic Neoplasms 2 Oropharyngeal Neoplasms 2 Lymphedema 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Glioma 2 Glioblastoma 2 Carcinoma, Squamous Cell 2 Brain Neoplasms 2 Atypical Squamous Cells of the Cervix 2 Xeroderma Pigmentosum 1 Triple Negative Breast Neoplasms 1 Trichothiodystrophy Syndromes 1 Tongue Neoplasms 1 Squamous Intraepithelial Lesions 1 Spinal Cord Neoplasms 1 Smoking Cessation 1 Smoking 1 Signs and Symptoms, Digestive 1 Sexual Dysfunction, Physiological 1 Rectal Neoplasms 1

Interventions

Cyclophosphamide 82 Etoposide 45 Carboplatin 38 Temozolomide 37 Filgrastim 37 Melphalan 36 Isotretinoin 36 Vincristine 35 Topotecan 35 Irinotecan 35 Doxorubicin 33 3-Iodobenzylguanidine 30 Granulocyte Colony-Stimulating Factor 26 Peripheral Blood Stem Cell Transplantation 25 Cisplatin 25 dinutuximab 22 sargramostim 21 Radiotherapy 21 Granulocyte-Macrophage Colony-Stimulating Factor 21 Busulfan 19 fludarabine 16 Magnetic Resonance Spectroscopy 16 naxitamab 14 aldesleukin 13 Thiotepa 13 Interleukin-2 13 fludarabine phosphate 12 humanized 3F8 anti-GD2 monoclonal antibody 11 etoposide phosphate 11 Biopsy 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02780128 2026-03-10

NEPENTHE

Children's Hospital of Philadelphia

Phase 1 Terminated

Neoplasms, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡